Barclays’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Sell |
|
|||||
|
2025
Q2 | $1.46M | Buy |
|
|||||
|
2025
Q1 | $991K | Sell |
|
|||||
|
2024
Q4 | $1.45M | Buy |
|
|||||
|
2024
Q3 | $1.44M | Buy |
|
|||||
|
2024
Q2 | $331K | Sell |
|
|||||
|
2024
Q1 | $462K | Sell |
|
|||||
|
2023
Q4 | $583K | Buy |
|
|||||
|
2023
Q3 | $186K | Sell |
|
|||||
|
2023
Q2 | $303K | Buy |
|
|||||
|
2023
Q1 | $158K | Buy |
|